G.D. Găman *, Amelia Găman *, C. Stancu *, Ionela Rotaru *, Alina Tănase *
* Dr. G.D. Găman, Amelia Găman, Ionela Rotaru, Alina Tănase – Clinica de Hematologie Craiova
Abstract
The treatment with intron A has determined in 11 CMLpacients: 8 partial remission (acute phase), 2 minimal remissions (accelerated phase) and 1 minimai remission (blastic phase).